Ms Celeste O'Callaghan:

At this stage, we have not done consultation of that kind because we are still doing the preliminary analysis. Once we have a baseline of options and the preliminary analysis is done, we anticipate that there would be a consultation exercise. We would certainly want to take on board the views of patient representatives and various advocacy groups, bearing in mind that this legislation is not disease-specific and will involve people with various kinds of conditions. We intend to engage with different advocacy groups as part of that consultation.